Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid.

AIMS AND PURPOSE: To identify patterns and rates of adherence with travoprost eye drops using the Travatan dosing aid (TDA) and to present a method for graphically presenting adherence data. METHODS: A prospective observational cohort study of patients on travoprost (prostaglandin) monotherapy. Patients were dispensed a TDA and followed up after approximately 3 months of usage. Data were downloaded from the TDA into a computer for analysis. Analysis used inter-dose intervals (the time between each dosing) to look at adherence between days 4 and 75. RESULTS: In all, 100 patients were invited to participate, 53 agreed and complete TDA data sets were obtained from 37. In total 23 of the complete data sets showed good adherence (dosing within +/-4 h of the agreed dosing time on >80% of occasions), 3 patients discontinued usage before 75 days, 4 showed frequent drug holidays (no dosing for > or =8 days) and 7 frequently missed doses with adherence rates of <60%. Of the 16 patients for whom no TDA data was obtained, 5 were lost to follow-up, 4 had faulty/damaged TDAs, 3 changed medication, 3 preferred not to use the TDA, and 1 was hospitalized. CONCLUSIONS: There were four easily defined patterns of adherence; (1) good adherence; (2) discontinued usage; (3) frequent drug holidays; and (4) frequent missed doses with low adherence rates. A new method for graphically presenting adherence data helps clinicians identify the pattern of usage and is a valuable aid to the overall management of patients on travoprost therapy.

Pulsatile ocular blood flow in eyes with untreated choroidal melanoma.

PURPOSE: To investigate the effect of choroidal melanoma on pulsatile ocular blood flow (POBF). METHODS: Seventeen patients (10 men and 7 women) with unilateral untreated choroidal melanoma and 22 controls matched for age and sex were studied. Intraocular pressure (IOP), pulse amplitude (PA) and POBF were measured using the OBF Tonograph. In each patient, mean inter-ocular differences were analysed using the paired t-test. The correlation coefficient between tumour thickness and POBF was calculated. To assess the variation of this parameter, the coefficient of variation for three repeated readings was determined for healthy and affected eyes. RESULTS: In the control group, there was no significant difference between eyes in any parameter. In patients with melanoma, there was no significant difference in IOP and PA between affected and unaffected eyes. Mean POBF was significantly higher in affected eyes (1040 microliters min-1) than unaffected eyes (876 microliters min-1) (p = 0.003). There was no correlation between tumour thickness and absolute POBF (r = -0.24) or between tumour thickness and inter-ocular difference in POBF between affected and unaffected eyes (r = -0.17). Mean coefficient of variation of three repeated readings of POBF was 7.76% in healthy eyes and 8.97% in affected eyes. CONCLUSIONS: These findings suggest a high tumour blood flow or a global increase in choroidal blood flow in the presence of melanoma. POBF measurement may be useful in the clinical assessment of eyes with choroidal melanoma.